跳至主要内容
临床试验/NCT06343103
NCT06343103Unknown不适用

Multicentric Study to Evaluate Occupational Exposure to Antineoplastic Drugs Through Genotoxics Markers and Enviromental Monitoring

European Institute of Oncology6 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年8月2日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
6
主要终点
Evaluation of the difference in micronuclei frequency

研究概览

简要总结

The multicenter study involves comparing two groups (an exposed group and a control group). The exposed group is selected from workers who perform their activities in drug handling areas (DH) or units for antineoplastic preparation (UFA), while the control group involves the voluntary participation of non-exposed workers (administrative staff).

The control group is selected based on the characteristics of the exposed group to ensure a homogeneous sample in terms of size and characteristics.

详细描述

The study will be proposed to all workers exposed to cytotoxic agents who have an employment contract or similar arrangement and who are affiliated with the hospital facilities participating in the protocol. Participation of workers in the study is voluntary.

The control group will be recruited from administrative staff and/or individuals not exposed to chemotherapy who have an employment contract or similar arrangement and who are affiliated with the hospital facilities participating in the protocol.

A subject is considered enrolled after signing the informed consent and will be considered evaluable if:

They have completed the exposure diary (only for the exposed group). They have responded to the medical history questionnaire. They have undergone sampling of oral mucosa exfoliated cells and blood collection.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old
  • Capacity to understand and consent
  • Personnel with an employment contract or similar arrangement
  • Ability to comply with the procedures outlined in the protocol
  • Signing of the informed consent

排除标准

  • Age < 18 years old
  • Any ongoing chemotherapy or radiation treatment for neoplasms of any kind
  • Planned diagnostic exams involving radiation within three weeks following the signing of the Informed Consent
  • Inability to comply with the procedures outlined in the protocol

结局指标

主要结局

Evaluation of the difference in micronuclei frequency

时间窗: 1 year

Correlation between the difference in micronuclei frequency ain the exposed and unexposed groups

次要结局

未报告次要终点

研究者

发起方
European Institute of Oncology
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验